TABLE 5.
Availability of Tailored Services for Specific Populations and Comparison with Adoption of AUD Pharmacotherapy
| Full Sample % (N) |
Offers AUD Pharmacotherapy % (N) |
No AUD Pharmacotherapy % (N) |
χ2 Test (Two Tailed) |
|
|---|---|---|---|---|
| Relapsing Individuals | 31.7% (116) | 35.3% (30) | 30.4% (84) | χ2 = 0.71, df = 1, p = .399 |
| Adolescents | 40.3% (147) | 41.7% (35) | 39.9% (110) | χ2 = 0.09, df = 1, p = .767 |
| Women | 57.0% (208) | 61.2% (52) | 55.6% (153) | χ2 = 0.81, df = 1, p = .367 |
| Pregnant Women | 19.5% (71) | 14.1% (12) | 21.2% (58) | χ2 = 2.05, df = 1, p = .152 |
| Spanish Speakers | 19.3% (70) | 21.2% (18) | 18.6% (51) | χ2 = 0.27, df = 1, p = .600 |
| Non-Hispanic Minorities | 5.2% (19) | 6.0% (5) | 5.1% (14) | χ2 = 0.10, df = 1, p = .758 |
| Lesbian, Gay, Bisexual and/or Transgendered Individuals | 6.3% (23) | 5.9% (5) | 6.6% (18) | χ2 = 0.05, df = 1, p = .827 |
| Individuals Living with HIV/AIDS | 8.0% (29) | 5.9% (5) | 8.7% (24) | χ2 = 0.71, df = 1, p = .400 |
| Homeless Individuals | 5.5% (20) | 0.0% (0) | 6.9% (19) | χ2 = 6.20, df = 1, p = .013 |
AUD, alcohol use disorder. Tailored services include distinct treatment tracks exclusively for a specific population or the availability of specific group or educational sessions for a specific population.